Willemin, Marie-Emilie https://orcid.org/0000-0002-1974-1170
Gong, Jue
Hilder, Brandi W.
Masterson, Tara
Tolbert, Jaszianne
Renaud, Thomas
Heuck, Christoph
Kane, Colleen
De Zwart, Loeckie
Girgis, Suzette
Ma, Xuewen
Ouellet, Daniele
Funding for this research was provided by:
Janssen Research and Development
Article History
Accepted: 20 August 2024
First Online: 16 September 2024
Declarations
:
: The study was funded by Janssen Research & Development and medical writing support was funded by Janssen Global Services.
: M-EW is employed by and has stock/other ownership interests in Janssen. JG is employed by Janssen at the time of the analysis and has stock/other ownership interests in Janssen. BWH is employed by Janssen Oncology and has stock/other ownership interests in Johnson & Johnson/Janssen. TM is employed by Janssen at the time of the analysis and has stock/other ownership interests in Janssen. JT is employed by Johnson & Johnson, has stock/other ownership interests in Johnson & Johnson, and has received research funding from Janssen Research & Development. TR is employed by Janssen Oncology and has stock/other ownership interests in Johnson & Johnson/Janssen. CH is employed by Janssen at the time of the analysis and has stock/other ownership interests in Janssen. CK is employed by Janssen at the time of the analysis and has stock/other ownership interests in Janssen. LDZ is employed by Janssen and has stock/other ownership interests in Janssen. SG is employed by Janssen at the time of the analysis, has stock/other ownership interests in Bristol Myers Squibb, Janssen, and Jazz Pharmaceuticals, and holds patents with Johnson & Johnson. XM is employed by Janssen at the time of the analysis and has stock/other ownership interests in Janssen. DO is employed by and has stock/other ownership interests in Janssen.
: Not applicable.
: Not applicable.
: Not applicable.
: The datasets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author upon reasonable request.
: The data sharing policy of Janssen Pharmaceutical Companies of Johnson & Johnson is available at . As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at .
: Not applicable.
: M-EW: wrote the manuscript, designed the research, performed the research, analyzed the data, and contributed significantly to the manuscript review and editing. JG: designed the research, performed the research, contributed to the data acquisition and interpretation, and writing (review and editing). BWH: contributed to conceptualization, data acquisition, investigation, methodology, validation, and writing (review and editing). TM: contributed to conceptualization, data acquisition, investigation, methodology, validation, and writing (review and editing). JT: contributed to conceptualization, data acquisition, investigation, methodology, validation, and writing (review and editing). TR: contributed to conceptualization, data acquisition, investigation, methodology, validation, and writing (review and editing). CH: contributed to conceptualization, data acquisition, investigation, methodology, validation, and writing (review and editing). CK: contributed to conceptualization, data acquisition, investigation, methodology, validation, and writing (review and editing). LDZ: designed the research, performed the research, analyzed the data, and contributed to writing (review and editing). SG: designed the research, contributed to the data analysis and interpretation, and writing (review and editing). XM: designed the research, analyzed the data, contributed to the data analysis and interpretation, and writing (review and editing). DO: designed the research, performed the research, analyzed the data, and contributed to writing (review and editing).